Target intelligence / Profile preview

Cellular and microbial membranes and proteins

Molecular classification
Other
01

Overview

Cellular and microbial membranes and proteins represent a broad classification of biological structures rather than a single, discrete therapeutic target. This category encompasses the phospholipid bilayers that define cellular boundaries and the vast array of proteins responsible for nearly all biological processes, including transport, signaling, and metabolism (Source: NIH). In pharmacology, this term often refers to the site of action for non-specific agents such as antiseptics and disinfectants, which achieve microbicidal effects by denaturing proteins and dissolving lipid membranes (Source: StatPearls). It also includes the targets of specific membrane-active antibiotics like Polymyxin B and Colistin, which bind to lipopolysaccharides and disrupt the outer membrane of Gram-negative bacteria (Source: PubChem). Other agents, such as the antifungal Amphotericin B, target specific components like ergosterol within microbial membranes to induce leakage (Source: FDA). Because this classification covers almost all biological machinery in both host and pathogen, it is considered too broad for specific drug design and carries significant risks of off-target toxicity if selectivity is not achieved.

Other names
Biological membranesCellular proteinsMicrobial cell wall and membrane componentsPlasma membranes
02

Mechanism of action

Drugs targeting these structures typically act through the physical disruption of the lipid bilayer, pore formation, or the non-specific denaturation of functional proteins (Source: StatPearls, PubChem).

03

Biological functions

Cellular integrityTransportSignal transductionMetabolismCellular compartmentalization
04

Disease associations

InfectionCancerInflammation
05

Safety considerations

Lack of selectivity between host and microbial cellsSystemic toxicity (e.g., nephrotoxicity, neurotoxicity)HemolysisCytotoxicity to host tissues
06

Interacting drugs

Polymyxin B

5 more in the full profile.

Beyond the preview

Go deeper on Cellular and microbial membranes and proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular and microbial membranes and proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call